Additionally, chemotherapeutic agents (e.g., cisplatin) induce tumor release of oxidized phospholipids (oxPAPC), which recruit MDSCs via palmitoylation-dependent MCP-1/CCL2 and LTB4/LTB4R pathways, ultimately leading to chemoresistance (189). This evidence concerns the gene CCL2 and neoplasm.